Location History:
- Seoul, KR (2018 - 2020)
- Chungcheongbuk-do, KR (2023)
Company Filing History:
2 out of 1,567 
1 out of 4 
1 out of 43 
Years Active: 2018-2023
Title: Innovator Spotlight: Yoon Shin Park
Introduction:
Yoon Shin Park, a renowned inventor based in Chungcheongbuk-do, South Korea, has made significant contributions to the field of stem cell research through his groundbreaking patent titled "GRP78-derived peptide for identifying high-efficiency stem cells."
Latest Patents:
Yoon Shin Park's notable patent involves a GRP78-derived peptide utilized for identifying highly efficient stem cells. This peptide targets the binding domain of the GRP78 protein on the cell surface, enabling the specific recognition of non-senescent young stem cells. By introducing this peptide to stem cells, their efficiency and efficacy can be significantly enhanced.
Career Highlights:
Throughout his career, Yoon Shin Park has been associated with esteemed companies and institutions such as Nibec Co., Ltd. and the Chungbuk National University Industry-academic Cooperation Foundation. His dedication to innovation and scientific research has led to the development of cutting-edge technologies in the field of stem cell therapy.
Collaborations:
Yoon Shin Park has collaborated with notable individuals in his field, including Yoon Jeong Park and Chong-Pyoung Chung. Together, they have conducted research and experiments aimed at further advancing stem cell technologies and therapies.
Conclusion:
In conclusion, Yoon Shin Park stands as a pioneering figure in the realm of stem cell research, with his patent paving the way for the identification and enhancement of high-efficiency stem cells. His collaborations and career highlights underscore his commitment to advancing scientific knowledge and improving healthcare through innovative inventions.